Browse drugs

…tion and sepsis rather than trigger empiric HF treatment alone. NT-proBNP should not be interpreted in isolation when assessing acutely u…

…ed in the community. N-terminal pro B-type natriuretic peptide (NT-proBNP) has variable sensitivity for HF across different subgroups, pa…

…s analysis of the OPT-PACE randomised controlled trial we found natriuretic peptides were frequently elevated in patients with pacemakers, and that …

…P concentrations but does not attenuate the prognostic value of NT-proBNP. Lowering guideline-recommended NT-proBNP thresholds for obese …

…I) for all-cause mortality were significant for each biomarker: NT-proBNP 1.35 (1.26-1.44); hs-cTnT 1.75 (1.48-2.07); hs-cTnI 1.33 (1.24-…

…firmed in 31 patients (PPV 62%), including 20 with HFrEF. Using NT-proBNP alone, efficiency was limited: 1.61 TTEs per confirmed HF and 2…

…8).Conclusions In a cohort of stabilised acute STEMI survivors, NT-proBNP was associated with all-cause mid-term mortality independent of…

…k of HFpEF that requires further testing (figure 1B).Conclusion NT-proBNP screening identified elevated biomarkers in 44% of patients wit…

…troduction N-terminal-pro hormone of Brain Natriuretic Peptide (NT-proBNP) is a sensitive rule-out test for new-onset acute heart failure…

…atients with significant systemic illness were excluded. Pre-op NT-proBNP, Troponin T, and ECGs were obtained. DCI was defined clinically…

…and social care trust carcinoid heart disease pathwayConclusion NT-proBNP is a useful screening tool for the detection of CHD in patients…

…by CTPA in 2/18 (11.1%) with normal or absent D-dimer. Elevated NT-proBNP prompted TTE in 20/31 patients (81%), identifying left ventricu…